• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C3d引发中性粒细胞脱颗粒并减少内皮细胞迁移,对α-1抗胰蛋白酶缺乏症患者具有重要意义。

C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.

作者信息

Fee Laura T, Gogoi Debananda, O'Brien Michael E, McHugh Emer, Casey Michelle, Gough Ciara, Murphy Mark, Hopkins Ann M, Carroll Tomás P, McElvaney Noel G, Reeves Emer P

机构信息

Alpha-1 Foundation Ireland, Royal College of Surgeons in Ireland, Beaumont Hospital, D02 YN77 Dublin, Ireland.

Irish Centre for Genetic Lung Disease, Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, D02 YN77 Dublin, Ireland.

出版信息

Biomedicines. 2021 Dec 16;9(12):1925. doi: 10.3390/biomedicines9121925.

DOI:10.3390/biomedicines9121925
PMID:34944741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8698851/
Abstract

Alpha-1 antitrypsin (AAT) deficiency (AATD) is characterized by increased risk for emphysema, chronic obstructive pulmonary disease (COPD), vasculitis, and wound-healing impairment. Neutrophils play a central role in the pathogenesis of AATD. Dysregulated complement activation in AATD results in increased plasma levels of C3d. The current study investigated the impact of C3d on circulating neutrophils. Blood was collected from AATD ( = 88) or non-AATD COPD patients ( = 10) and healthy controls (HC) ( = 40). Neutrophils were challenged with C3d, and degranulation was assessed by Western blotting, ELISA, or fluorescence resonance energy transfer (FRET) substrate assays. Ex vivo, C3d levels were increased in plasma ( < 0.0001) and on neutrophil plasma membranes ( = 0.038) in AATD compared to HC. C3d binding to CR3 receptors triggered primary ( = 0.01), secondary ( = 0.004), and tertiary ( = 0.018) granule release and increased CXCL8 secretion ( = 0.02). Ex vivo plasma levels of bactericidal-permeability-increasing-protein ( = 0.02), myeloperoxidase ( < 0.0001), and lactoferrin ( < 0.0001) were significantly increased in AATD patients. In endothelial cell scratch wound assays, C3d significantly decreased cell migration ( < 0.0001), an effect potentiated by neutrophil degranulated proteins ( < 0.0001). In summary, AATD patients had increased C3d in plasma and on neutrophil membranes and, together with neutrophil-released granule enzymes, reduced endothelial cell migration and wound healing, with potential implications for AATD-related vasculitis.

摘要

α1抗胰蛋白酶(AAT)缺乏症(AATD)的特征是患肺气肿、慢性阻塞性肺疾病(COPD)、血管炎和伤口愈合受损的风险增加。中性粒细胞在AATD的发病机制中起核心作用。AATD中补体激活失调导致血浆C3d水平升高。本研究调查了C3d对循环中性粒细胞的影响。从AATD患者(n = 88)、非AATD的COPD患者(n = 10)和健康对照者(HC)(n = 40)采集血液。用C3d刺激中性粒细胞,并通过蛋白质免疫印迹法、酶联免疫吸附测定(ELISA)或荧光共振能量转移(FRET)底物测定法评估脱颗粒情况。在体外,与HC相比,AATD患者血浆中C3d水平升高(P < 0.0001),中性粒细胞质膜上的C3d水平也升高(P = 0.038)。C3d与CR3受体结合触发初级颗粒(P = 0.01)、次级颗粒(P = 0.004)和三级颗粒释放(P = 0.018),并增加CXCL8分泌(P = 0.02)。AATD患者体外血浆中杀菌通透性增加蛋白水平(P = 0.02)、髓过氧化物酶水平(P < 0.0001)和乳铁蛋白水平(P < 0.0001)显著升高。在内皮细胞划痕试验中,C3d显著降低细胞迁移(P < 0.0001),中性粒细胞脱颗粒蛋白可增强这一效应(P < 0.0001)。总之,AATD患者血浆和中性粒细胞膜上的C3d增加,并且与中性粒细胞释放的颗粒酶一起,降低了内皮细胞迁移和伤口愈合能力,这可能与AATD相关的血管炎有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/01fc2c5aa56c/biomedicines-09-01925-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/9053a94378b1/biomedicines-09-01925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/15608c491b3d/biomedicines-09-01925-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/7fd294cd51c3/biomedicines-09-01925-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/2c4b47428aac/biomedicines-09-01925-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/7df055a591d3/biomedicines-09-01925-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/958193c9263e/biomedicines-09-01925-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/01fc2c5aa56c/biomedicines-09-01925-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/9053a94378b1/biomedicines-09-01925-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/15608c491b3d/biomedicines-09-01925-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/7fd294cd51c3/biomedicines-09-01925-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/2c4b47428aac/biomedicines-09-01925-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/7df055a591d3/biomedicines-09-01925-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/958193c9263e/biomedicines-09-01925-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8c1/8698851/01fc2c5aa56c/biomedicines-09-01925-g007.jpg

相似文献

1
C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.C3d引发中性粒细胞脱颗粒并减少内皮细胞迁移,对α-1抗胰蛋白酶缺乏症患者具有重要意义。
Biomedicines. 2021 Dec 16;9(12):1925. doi: 10.3390/biomedicines9121925.
2
Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.补体成分 3 的激活与α-1 抗胰蛋白酶缺乏症中的气道疾病和肺肺气肿有关。
Thorax. 2020 Apr;75(4):321-330. doi: 10.1136/thoraxjnl-2019-214076. Epub 2020 Jan 20.
3
α Antitrypsin therapy modulates the neutrophil membrane proteome and secretome.α1抗胰蛋白酶疗法可调节中性粒细胞的膜蛋白质组和分泌蛋白质组。
Eur Respir J. 2020 Apr 30;55(4). doi: 10.1183/13993003.01678-2019. Print 2020 Apr.
4
Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.α1-抗胰蛋白酶增敏抑制α1 缺乏个体中性粒细胞膜电压门控质子通道 1 的蛋白水解。
Medicina (Kaunas). 2021 Aug 10;57(8):814. doi: 10.3390/medicina57080814.
5
Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals.缺乏α-1 抗胰蛋白酶个体的单核细胞 NLRP3 炎性小体和白细胞介素-1β 的激活受 α-1 抗胰蛋白酶治疗的调节。
Thorax. 2024 Aug 19;79(9):822-833. doi: 10.1136/thorax-2023-221071.
6
The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.循环蛋白酶抑制剂 α-1 抗胰蛋白酶调节中性粒细胞脱粒和自身免疫。
Sci Transl Med. 2014 Jan 1;6(217):217ra1. doi: 10.1126/scitranslmed.3007116.
7
Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.α-1 抗胰蛋白酶疗法可改变阻塞性肺疾病患者中性粒细胞的黏附
Am J Respir Cell Mol Biol. 2022 Jul;67(1):76-88. doi: 10.1165/rcmb.2021-0433OC.
8
The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.α-1抗胰蛋白酶增强疗法的BLT1抑制功能破坏白三烯B4中性粒细胞信号传导。
J Immunol. 2015 Oct 15;195(8):3628-41. doi: 10.4049/jimmunol.1500038. Epub 2015 Sep 14.
9
Impact of Hypoxia on Neutrophil Degranulation and Inflammatory Response in Alpha-1 Antitrypsin Deficiency Patients.缺氧对α-1抗胰蛋白酶缺乏症患者中性粒细胞脱颗粒和炎症反应的影响。
Antioxidants (Basel). 2024 Sep 2;13(9):1071. doi: 10.3390/antiox13091071.
10
Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools.α1 抗胰蛋白酶缺乏症的心血管疾病:一项观察性研究,评估中性粒细胞蛋白酶活性的作用和经过验证的筛选工具的适用性。
Orphanet J Rare Dis. 2024 Mar 21;19(1):130. doi: 10.1186/s13023-024-03124-x.

引用本文的文献

1
Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis.通过 ATF6 增强蛋白质稳态来捕获致病性 α1-抗胰蛋白酶折叠的转化。
Cell Chem Biol. 2023 Jan 19;30(1):22-42.e5. doi: 10.1016/j.chembiol.2022.12.004. Epub 2023 Jan 10.
2
Neutrophils, Fast and Strong.中性粒细胞,快速且强大。
Biomedicines. 2022 Aug 21;10(8):2040. doi: 10.3390/biomedicines10082040.
3
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.α1-抗胰蛋白酶结合蛋白的免疫调节作用及潜在治疗应用研究进展

本文引用的文献

1
Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.α1-抗胰蛋白酶增敏抑制α1 缺乏个体中性粒细胞膜电压门控质子通道 1 的蛋白水解。
Medicina (Kaunas). 2021 Aug 10;57(8):814. doi: 10.3390/medicina57080814.
2
Avacopan for the treatment of ANCA-associated vasculitis.阿伐考潘治疗抗中性粒细胞胞质抗体相关性血管炎。
Expert Rev Clin Immunol. 2021 Jul;17(7):717-726. doi: 10.1080/1744666X.2021.1932466. Epub 2021 May 28.
3
Alpha-1 antitrypsin deficiency-associated panniculitis.
Int J Mol Sci. 2022 Feb 23;23(5):2441. doi: 10.3390/ijms23052441.
α-1 抗胰蛋白酶缺乏相关性脂膜炎。
J Am Acad Dermatol. 2022 Oct;87(4):825-832. doi: 10.1016/j.jaad.2021.01.074. Epub 2021 Jan 29.
4
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women.丝氨酸蛋白酶抑制剂A1(SERPINA1)基因启动子在孕妇外周血单个核细胞中存在差异甲基化。
Front Cell Dev Biol. 2020 Sep 3;8:550543. doi: 10.3389/fcell.2020.550543. eCollection 2020.
5
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis.靶向IgG自身抗体以提高囊性纤维化中杀菌通透性增加蛋白的细胞毒性
Front Pharmacol. 2020 Jul 17;11:1098. doi: 10.3389/fphar.2020.01098. eCollection 2020.
6
α Antitrypsin therapy modulates the neutrophil membrane proteome and secretome.α1抗胰蛋白酶疗法可调节中性粒细胞的膜蛋白质组和分泌蛋白质组。
Eur Respir J. 2020 Apr 30;55(4). doi: 10.1183/13993003.01678-2019. Print 2020 Apr.
7
Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.补体成分 3 的激活与α-1 抗胰蛋白酶缺乏症中的气道疾病和肺肺气肿有关。
Thorax. 2020 Apr;75(4):321-330. doi: 10.1136/thoraxjnl-2019-214076. Epub 2020 Jan 20.
8
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.活化的 PMN 外泌体:导致肺部基质破坏和疾病的致病实体。
Cell. 2019 Jan 10;176(1-2):113-126.e15. doi: 10.1016/j.cell.2018.12.002.
9
Structural Immunology of Complement Receptors 3 and 4.补体受体 3 和 4 的结构免疫学
Front Immunol. 2018 Nov 26;9:2716. doi: 10.3389/fimmu.2018.02716. eCollection 2018.
10
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia.糖基化作用使α-1抗胰蛋白酶重新用于社区获得性肺炎的消退。
Am J Respir Crit Care Med. 2018 May 15;197(10):1346-1349. doi: 10.1164/rccm.201709-1954LE.